Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat. (Q32078137)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11230997%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11230997%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11230997%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Sacco G

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11230997%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Bigioni M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11230997%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Goso C

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11230997%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Manzini S

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11230997%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Maggi CA

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11230997%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11230997%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11230997%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11230997%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11230997%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

71-78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11230997%20AND%20SRC:MED&resulttype=core&format=json

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Early and delayed clinical cardiotoxicity of doxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Cardiac morphologic and functional changes induced by epirubicin chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Preclinical pharmacology of zofenopril, an inhibitor of angiotensin I converting enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Molecular plasticity of vascular wall during N(G)-nitro-L-arginine methyl ester-induced hypertension: modulation of proinflammatory signals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

The impact of induction anthracycline on long-term failure-free survival in childhood acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: the role of reactive oxygen and nitrogen intermediates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

A clinicopathologic analysis of adriamycin cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Protective effects of captopril and enalapril on myocardial ischemia and reperfusion damage of rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

An angiotensin-converting enzyme inhibitor protects against doxorubicin-induced impairment of calcium handling in neonatal rat cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Equipotent antihypertensive agents variously affect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Current status of epirubicin (Farmorubicin) in the treatment of solid tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Beneficial effects of ACE-inhibition with zofenopril on plaque formation and low-density lipoprotein oxidation in watanabe heritable hyperlipidemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Chronic cardiotoxicity of doxorubicin (adriamycin) in the rat: morphologic and biochemical investigations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Etiology of sarcoplasmic reticulum calcium release channel lesions in doxorubicin-induced cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Anthracyclines and the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Doxorubicin-induced cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Preclinical Profile of Zofenopril: An Angiotensin Converting Enzyme Inhibitor with Peculiar Cardioprotective Properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisinopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Prevention of doxorubicin (adriamycin)-induced cardiomyopathy by simultaneous administration of angiotensin-converting enzyme inhibitor assessed by acoustic densitometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

UKCCCR guidelines for the welfare of animals in experimental neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Usefulness of a free radical scavenger in preventing doxorubicin-induced heart failure in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Relationship between doxorubicin-induced ECG changes and myocardial alterations in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Risk factors for doxorubicin-induced congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Effects of doxorubicin on excitation-contraction coupling in guinea pig ventricular myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

Induction of antioxidants by adriamycin in mouse heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900782-8

10.1016/S0014-2999(01)00782-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11230997%20AND%20SRC:MED&resulttype=core&format=json

release_pe5gcd2ffrhhfeolcx4romzvia

5 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pe5gcd2ffrhhfeolcx4romzvia

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference